Press Releases
CPi Biotech utilises low shear, low pulsation pumps from Watson-Marlow for its bioprocess skids
Peristaltic pumps from Watson-Marlow Fluid Technology Solutions (WMFTS) have been integrated into CPi Biotech’s advanced bioprocess skids
CPi Biotech is using a range of...
Press Releases
Exploring Unlimited Packaging Opportunities at swop 2024: Bringing together the Emerging Forces of the Industry and Driving the New Development of Packaging
With the expansion of the global consumer market and the development of technological updates, the packaging industry has become a major driver of economic growth....
Packaging & Labelling
Syntegon launches new SBM Essential Line sterilizers: standardization for shorter delivery times
With the SBM Essential Line, the Syntegon subsidiary Schoeller-Bleckmann Medizintechnik (SBM) launches a new series of its sterilizers, which are based on 50 years of...
Drug Research
Elsevier and Iktos partner to deliver an AI-driven synthetic chemistry platform for drug discovery
Elsevier, a global leader in information and data analytics, has signed a multi-year agreement with Iktos, a company specializing in artificial intelligence for new drug...
Drug Research
Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing
Charles River Laboratories International, Inc. announced a strategic agreement with Wheeler Bio, Inc., an antibody contract development and manufacturing organization (CDMO) focused on preclinical and...
Drug Research
Resilience Expands Clinical and Commercial Drug Product Manufacturing Capabilities and Capacities
National Resilience, Inc. (Resilience), Expands Clinical and Commercial Drug Product Manufacturing Capabilities and CapacitiesNational Resilience, Inc. , a technology-focused biomanufacturing company dedicated to broadening access...
Drug Research
AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific Biologics for Oncology and Immunology
AbbVie Inc. and Tentarix Biotherapeutics today announced a multi-year collaboration focused on the discovery and development of conditionally-active, multi-specific biologic candidates in oncology and immunology....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.